Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of California, Irvine
AgonOx, Inc.
M.D. Anderson Cancer Center
British Columbia Cancer Agency
Milton S. Hershey Medical Center
Marengo Therapeutics, Inc.
University of California, Irvine
Stanford University
University of Toronto
Advaxis, Inc.
National Institutes of Health Clinical Center (CC)
Milton S. Hershey Medical Center
Massachusetts General Hospital
Celldex Therapeutics
Merck Sharp & Dohme LLC
M.D. Anderson Cancer Center
Pharmacyclics LLC.